Gene · 6504
Papers3,484
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 3,484
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Profound phenotypic and epigenetic heterogeneity of the HIV-1-infected CD4+ T cell reservoir. | Nat Immunol | 2023 | 36536105 | PubTator, text mining | PubMed |
| Persistent and Severe Viral Replication in PBMCs with Moderate Immunosuppression Served an Alternative Novel Pathogenic Mechanism for Canine Morbillivirus. | Microbiol Spectr | 2023 | 36533959 | PubTator, text mining | PubMed |
| Current Developments in the Preclinical and Clinical use of Natural Killer T cells. | BioDrugs | 2023 | 36525216 | PubTator, text mining | PubMed |
| Paramyxoviruses from bats: changes in receptor specificity and their role in host adaptation. | Curr Opin Virol | 2023 | 36508860 | PubTator, text mining | PubMed |
| Comparison of Proteomic Measurements Across Platforms in the Atherosclerosis Risk in Communities (ARIC) Study. | Clin Chem | 2023 | 36508319 | PubTator, text mining | PubMed |
| A comparison of the International Consensus and 5th World Health Organization classifications of mature B-cell lymphomas. | Leukemia | 2023 | 36460764 | PubTator, text mining | PubMed |
| They shall not grow mold: Soldiers of innate and adaptive immunity to fungi. | Semin Immunol | 2023 | 36459927 | PubTator, text mining | PubMed |
| Low c-Kit expression identifies primitive, therapy-resistant CML stem cells. | JCI Insight | 2023 | 36413413 | PubTator, text mining | PubMed |
| Immune predictors of hepatitis B surface antigen seroconversion in patients with hepatitis B reactivation. | Aliment Pharmacol Ther | 2023 | 36411952 | PubTator, text mining | PubMed |
| Distinct inflammation-related proteins associated with T cell immune recovery during chronic HIV-1 infection. | Emerg Microbes Infect | 2023 | 36408648 | PubTator, text mining | PubMed |
| The emerging field of oncolytic virus-based cancer immunotherapy. | Trends Cancer | 2023 | 36402738 | PubTator, text mining | PubMed |
| Chronic inflammation decreases HSC fitness by activating the druggable Jak/Stat3 signaling pathway. | EMBO Rep | 2023 | 36341527 | PubTator, text mining | PubMed |
| Human natural killer cells: Form, function, and development. | J Allergy Clin Immunol | 2023 | 36195172 | PubTator, text mining | PubMed |
| Disease-Defining Molecular Features of Primary Cutaneous B-Cell Lymphomas: Implications for Classification and Treatment. | J Invest Dermatol | 2023 | 36163302 | PubTator, text mining | PubMed |
| The Role of Macrophages and Alveolar Epithelial Cells in the Development of ARDS. | Inflammation | 2023 | 36048270 | PubTator, text mining | PubMed |
| Epstein-Barr virus and multiple sclerosis. | Nat Rev Microbiol | 2023 | 35931816 | PubTator, text mining | PubMed |
| p16INK4A-dependent senescence in the bone marrow niche drives age-related metabolic changes of hematopoietic progenitors. | Blood Adv | 2023 | 35622970 | PubTator, text mining | PubMed |
| Self-replicating vehicles based on negative strand RNA viruses. | Cancer Gene Ther | 2023 | 35169298 | PubTator, text mining | PubMed |
| CD47-blocking Antibody ZL-1201 Promotes Tumor-associated Macrophage Phagocytic Activity and Enhances the Efficacy of the Therapeutic Antibodies and Chemotherapy. | Cancer Res Commun | 2022 | 36970051 | PubTator, text mining | PubMed |
| Optimizing Blood Stem Cell Transplants Through Cellular Engineering. | Blood Cell Ther | 2022 | 36714264 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6504/papers?page=25